NO165662C - Fremgangsmaate for fremstilling av en sakkaridnedbrytningsinhiberende sammensetning. - Google Patents

Fremgangsmaate for fremstilling av en sakkaridnedbrytningsinhiberende sammensetning.

Info

Publication number
NO165662C
NO165662C NO860826A NO860826A NO165662C NO 165662 C NO165662 C NO 165662C NO 860826 A NO860826 A NO 860826A NO 860826 A NO860826 A NO 860826A NO 165662 C NO165662 C NO 165662C
Authority
NO
Norway
Prior art keywords
inhibitor
succaride
procedure
preparation
degree
Prior art date
Application number
NO860826A
Other languages
English (en)
Norwegian (no)
Other versions
NO860826L (no
NO165662B (no
Inventor
Takao Matsuo
Satoshi Horii
Nobuyuki Kitamori
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP1985/000118 external-priority patent/WO1986005094A1/ja
Priority claimed from PCT/JP1985/000246 external-priority patent/WO1986006276A1/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO860826L publication Critical patent/NO860826L/no
Publication of NO165662B publication Critical patent/NO165662B/no
Publication of NO165662C publication Critical patent/NO165662C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/133—Amines having hydroxy groups, e.g. sphingosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO860826A 1985-03-08 1986-03-05 Fremgangsmaate for fremstilling av en sakkaridnedbrytningsinhiberende sammensetning. NO165662C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/JP1985/000118 WO1986005094A1 (fr) 1985-03-08 1985-03-08 Agent antiobesite et composition
PCT/JP1985/000246 WO1986006276A1 (fr) 1985-04-30 1985-04-30 Agent et composition inhibiteurs de la digestion du sucre

Publications (3)

Publication Number Publication Date
NO860826L NO860826L (no) 1986-09-09
NO165662B NO165662B (no) 1990-12-10
NO165662C true NO165662C (no) 1991-03-20

Family

ID=26425971

Family Applications (1)

Application Number Title Priority Date Filing Date
NO860826A NO165662C (no) 1985-03-08 1986-03-05 Fremgangsmaate for fremstilling av en sakkaridnedbrytningsinhiberende sammensetning.

Country Status (7)

Country Link
EP (1) EP0194794A3 (ja)
JP (1) JPH072647B2 (ja)
AU (1) AU596961B2 (ja)
CA (1) CA1255591A (ja)
DK (1) DK97986A (ja)
FI (1) FI860967L (ja)
NO (1) NO165662C (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61205455A (ja) * 1985-03-11 1986-09-11 Takeda Chem Ind Ltd 低カロリ−砂糖含有組成物
DE68905424T2 (de) * 1988-08-22 1993-06-24 Takeda Chemical Industries Ltd Alpha-glucosidaseinhibitor zur foerderung der calciumabsorption.
US7097845B2 (en) * 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
EP1022028A1 (en) * 1997-08-27 2000-07-26 Takeda Chemical Industries, Ltd. Sustained-release oral preparation
WO1999026606A2 (en) * 1997-11-25 1999-06-03 Bayer Aktiengesellschaft SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
JP4580542B2 (ja) * 2000-05-17 2010-11-17 株式會社バイオニア 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物
US7022684B2 (en) 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
WO2010110374A1 (ja) * 2009-03-26 2010-09-30 ビオフェルミン製薬株式会社 血糖降下作用増強剤
WO2012011174A1 (ja) * 2010-07-22 2012-01-26 ビオフェルミン製薬株式会社 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
WO2013081563A2 (en) * 2011-10-24 2013-06-06 Mahmut Bilgic Stable tablet formulations
KR101697260B1 (ko) * 2015-07-27 2017-01-17 고려대학교 산학협력단 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品
JP7595342B2 (ja) * 2021-02-03 2024-12-06 高梨乳業株式会社 抗ストレス用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7012090A (en) * 1970-08-17 1972-02-21 Bifidogen complex
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
EP0075604A1 (en) * 1981-09-24 1983-04-06 Asahi Kasei Kogyo Kabushiki Kaisha Blood glucose level-lowering agent

Also Published As

Publication number Publication date
JPH072647B2 (ja) 1995-01-18
EP0194794A2 (en) 1986-09-17
AU596961B2 (en) 1990-05-24
NO860826L (no) 1986-09-09
DK97986D0 (da) 1986-03-04
CA1255591A (en) 1989-06-13
FI860967A7 (fi) 1986-09-09
AU5427186A (en) 1986-09-11
FI860967L (fi) 1986-09-09
EP0194794A3 (en) 1986-12-17
NO165662B (no) 1990-12-10
JPS61205215A (ja) 1986-09-11
DK97986A (da) 1986-09-09
FI860967A0 (fi) 1986-03-07

Similar Documents

Publication Publication Date Title
FI860967A0 (fi) Fetma motverkande medel.
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
IL153989A (en) Nutritional composition comprising mixture of functional carbohydrates
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
NO940376D0 (no) Doseringsanordning for avgivelse av medikament over et tidsrom med kort varighet
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
TNSN99163A1 (fr) COMPOSITION ANTIOXYDANTE COMPRENANT L'ACETYL-CARNITINE ET L'ACIDE α -LIPOIQUE QUI AMELIORE L'UTILISATION METABOLIQUE DU GLUCOSE
DE69429297D1 (de) Zusammensetzung zur Behandlung von Patienten mit Lebererkrankungen
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
ATE71629T1 (de) Methylenphosphonalkylphosphinate, pharmazeutische zubereitungen und verfahren zur behandlung abnormalen kalzium- und phosphat-stoffwechsels.
PH25313A (en) Carboxylic acid derivatives, pharmaceutical compositions containing them
KR970061244A (ko) 치매 치료용 약학 조성물
GR82544B (en) Pharmaceutical preparation with 1,2-diacyl-glycero-3-phospholines for treating stomach and intestinal disorders
ATE184788T1 (de) Idebenone-haltige zusammensetzungen zur behandlung von m. alzheimer
ZA855822B (en) Pharmaceutical compositions for the treatment of involutional brain syndromes and mental decay
ATE56148T1 (de) Orales dextran enthaltende zusammensetzungen.
BR0015102A (pt) Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase
TR200100897T2 (tr) Lipid metabolizma bozukluklarının tedavisinde safra asitleriyle bağlı propanolamin türevleri.
GR82545B (en) Pharmaceutical preparation for treating rheumatics
JPS57126420A (en) Drug for digestive organ
ATE114471T1 (de) Verfahren zur behandlung und vorbeugung des verlustes von knochenmasse.
IL90528A0 (en) Propanolamine derivatives,their preparation and pharmaceutical compositions containing them
EG17992A (en) Preparation of a medicament for arthritis and theumatism
JPS554397A (en) Novel n11benzoylln22phenyll1*33diaminopropane 22ol*its manufacture and medicine containing it for therapy of acute and chronic gastritis
RU2156124C1 (ru) Способ профилактики кариеса зубов